Recurrent GBM samples expressing high MPO or CD66B gene levels were positively correlated with TAN markers (Fig. 7a; and Supplementary Fig. 10a) and cytokine/chemokine gene expression (Fig. 7b; and Supplementary Fig. 10b) [29]. The gene discussed is MPO; the disease is glioblastoma.